Gene therapies are proving their worth, but with million dollar price tags, it’s not clear who should pay for them

Sterghios Moschos

Research output: Contribution to specialist publication › Article

Keywords

@misc{94f16599be3a43719034b759cc16ad82,

title = "Gene therapies are proving their worth, but with million dollar price tags, it{\textquoteright}s not clear who should pay for them",

keywords = "gene therapy, pricing models, antisense, charity, genetic disease, inherited disease, siRNA, drug approval, regulator, FDA, EMA",

author = "Sterghios Moschos",

year = "2018",

month = mar,

day = "26",

language = "English",

journal = "The Conversation",

issn = "2201-5639",

publisher = "The Conversation Trust (UK)",

}

TY - GEN

T1 - Gene therapies are proving their worth, but with million dollar price tags, it’s not clear who should pay for them

AU - Moschos, Sterghios

PY - 2018/3/26

Y1 - 2018/3/26

KW - gene therapy

KW - pricing models

KW - antisense

KW - charity

KW - genetic disease

KW - inherited disease

KW - siRNA

KW - drug approval

KW - regulator

KW - FDA

KW - EMA

M3 - Article

SN - 2201-5639

SN - 1950-6244

SN - 2201-5639

JO - The Conversation

JF - The Conversation

ER -